Aclaris reports promising interim data from phase II trial of ATI-501 in severe alopecia areata June 29, 2018 No Comments
Aclaris initiates phase II trial of ATI-501 for alopecia totalis and alopecia universalis June 27, 2018 No Comments
Argenx reports cohort 1 interim data from phase II study of efgartigimod in pemphigus vulgaris June 20, 2018 No Comments
RSS